Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
| dc.contributor.author | De Boer, R. | |
| dc.contributor.author | Kotasek, D. | |
| dc.contributor.author | White, S. | |
| dc.contributor.author | Koczwara, B. | |
| dc.contributor.author | Mainwaring, P. | |
| dc.contributor.author | Chan, Arlene | |
| dc.contributor.author | Melara, R. | |
| dc.contributor.author | Ye, Y. | |
| dc.contributor.author | Adewoye, A. | |
| dc.contributor.author | Sikorski, R. | |
| dc.contributor.author | Kaufman, P. | |
| dc.date.accessioned | 2017-01-30T12:08:21Z | |
| dc.date.available | 2017-01-30T12:08:21Z | |
| dc.date.created | 2014-11-19T01:13:18Z | |
| dc.date.issued | 2012 | |
| dc.identifier.citation | De Boer, R. and Kotasek, D. and White, S. and Koczwara, B. and Mainwaring, P. and Chan, A. and Melara, R. et al. 2012. Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer. Breast Cancer Research and Treatment. 135 (1): pp. 241-252. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/18532 | |
| dc.publisher | Springer New York LLC | |
| dc.title | Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer | |
| dc.type | Journal Article | |
| dcterms.source.volume | 135 | |
| dcterms.source.number | 1 | |
| dcterms.source.startPage | 241 | |
| dcterms.source.endPage | 252 | |
| dcterms.source.issn | 01676806 | |
| dcterms.source.title | Breast Cancer Research and Treatment | |
| curtin.accessStatus | Fulltext not available |